Your institution may have access to this item. Find your institution then sign in to continue.
Title
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
Authors
Morris, John C; Roe, Catherine M; Grant, Elizabeth A; Head, Denise; Storandt, Martha; Goate, Alison M; Fagan, Anne M; Holtzman, David M; Mintun, Mark A
Abstract
To determine whether preclinical Alzheimer disease (AD), as detected by the amyloid-imaging agent Pittsburgh Compound B (PiB) in cognitively normal older adults, is associated with risk of symptomatic AD.
Publication
Archives of neurology, 2009, Vol 66, Issue 12, p1469